| Analysis | Metabolite Name | Measured Value | Units | DONOR CAUSE OF DEATH | SEX | Hep C Positive Donor |
|---|---|---|---|---|---|---|
| Reversed phase POSITIVE ION MODE | 3-UREIDOPROPIONATE | 117000.0000 | Peak area | CVA | F | NO |
| Reversed phase POSITIVE ION MODE | 3-UREIDOPROPIONATE | 154000.0000 | Peak area | Trauma | M | NO |
| Reversed phase POSITIVE ION MODE | 3-UREIDOPROPIONATE | 235000.0000 | Peak area | Anoxia | F | NO |
| Reversed phase POSITIVE ION MODE | 3-UREIDOPROPIONATE | 241000.0000 | Peak area | Anoxia | F | NO |
| Reversed phase POSITIVE ION MODE | 3-UREIDOPROPIONATE | 246000.0000 | Peak area | Anoxia | M | NO |
| Reversed phase POSITIVE ION MODE | 3-UREIDOPROPIONATE | 251000.0000 | Peak area | Anoxia | M | NO |
| Reversed phase POSITIVE ION MODE | 3-UREIDOPROPIONATE | 282000.0000 | Peak area | Cerebrovascular/Stroke | F | NO |
| Reversed phase POSITIVE ION MODE | 3-UREIDOPROPIONATE | 286000.0000 | Peak area | Anoxia | F | NO |
| Reversed phase POSITIVE ION MODE | 3-UREIDOPROPIONATE | 287000.0000 | Peak area | Anoxia | F | NO |
| Reversed phase POSITIVE ION MODE | 3-UREIDOPROPIONATE | 301000.0000 | Peak area | Anoxia | M | NO |
| Reversed phase POSITIVE ION MODE | 3-UREIDOPROPIONATE | 316000.0000 | Peak area | Trauma | F | NO |
| Reversed phase POSITIVE ION MODE | 3-UREIDOPROPIONATE | 376000.0000 | Peak area | Trauma | M | NO |
| Reversed phase POSITIVE ION MODE | 3-UREIDOPROPIONATE | 514000.0000 | Peak area | Cerebrovascular/Stroke | F | NO |
| Reversed phase POSITIVE ION MODE | 3-UREIDOPROPIONATE | 576000.0000 | Peak area | Anoxia | F | NO |
| Reversed phase POSITIVE ION MODE | 3-UREIDOPROPIONATE | 631000.0000 | Peak area | Trauma | M | NO |
| Reversed phase POSITIVE ION MODE | 3-UREIDOPROPIONATE | 640000.0000 | Peak area | Trauma | M | NO |
| Reversed phase POSITIVE ION MODE | 3-UREIDOPROPIONATE | 689000.0000 | Peak area | Trauma | F | NO |
| Reversed phase POSITIVE ION MODE | 3-UREIDOPROPIONATE | 703000.0000 | Peak area | Trauma | M | NO |
| Reversed phase POSITIVE ION MODE | 3-UREIDOPROPIONATE | 840000.0000 | Peak area | Anoxia | M | YES |
| Reversed phase POSITIVE ION MODE | 3-UREIDOPROPIONATE | 888000.0000 | Peak area | Trauma | M | NO |
| Reversed phase POSITIVE ION MODE | 3-UREIDOPROPIONATE | 1420000.0000 | Peak area | Trauma | M | NO |
| Reversed phase POSITIVE ION MODE | 3-UREIDOPROPIONATE | 1580000.0000 | Peak area | Trauma | M | NO |
| Reversed phase POSITIVE ION MODE | 3-UREIDOPROPIONATE | 2220000.0000 | Peak area | CVA | M | NO |
| Reversed phase POSITIVE ION MODE | 3-UREIDOPROPIONATE | 3180000.0000 | Peak area | Cerebrovascular/Stroke | M | NO |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|